Topol, G.A.; Pestalardo, I.G.; Reeves, K.D.; Elias, F.; Steinmetz, N.J.; Cheng, A.-L.; Rabago, D.
Dextrose Prolotherapy for Symptomatic Grade IV Knee Osteoarthritis: A Pilot Study of Early and Longer-Term Analgesia and Pain-Specific Cytokine Concentrations. Clin. Pract. 2022, 12, 926-938.
https://doi.org/10.3390/clinpract12060097
AMA Style
Topol GA, Pestalardo IG, Reeves KD, Elias F, Steinmetz NJ, Cheng A-L, Rabago D.
Dextrose Prolotherapy for Symptomatic Grade IV Knee Osteoarthritis: A Pilot Study of Early and Longer-Term Analgesia and Pain-Specific Cytokine Concentrations. Clinics and Practice. 2022; 12(6):926-938.
https://doi.org/10.3390/clinpract12060097
Chicago/Turabian Style
Topol, Gastón Andrés, Ines Guerrero Pestalardo, Kenneth Dean Reeves, Fernando Elias, Neven J. Steinmetz, An-Lin Cheng, and David Rabago.
2022. "Dextrose Prolotherapy for Symptomatic Grade IV Knee Osteoarthritis: A Pilot Study of Early and Longer-Term Analgesia and Pain-Specific Cytokine Concentrations" Clinics and Practice 12, no. 6: 926-938.
https://doi.org/10.3390/clinpract12060097
APA Style
Topol, G. A., Pestalardo, I. G., Reeves, K. D., Elias, F., Steinmetz, N. J., Cheng, A.-L., & Rabago, D.
(2022). Dextrose Prolotherapy for Symptomatic Grade IV Knee Osteoarthritis: A Pilot Study of Early and Longer-Term Analgesia and Pain-Specific Cytokine Concentrations. Clinics and Practice, 12(6), 926-938.
https://doi.org/10.3390/clinpract12060097
